4.7 Meeting Abstract

Phase III, randomized trial (CheckMate 057) of nivolumab (NIVO) versus docetaxel (DOC) in advanced non-squamous cell (non-SQ) non-small cell lung cancer (NSCLC)

Journal

JOURNAL OF CLINICAL ONCOLOGY
Volume 33, Issue 18, Pages -

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1200/jco.2015.33.18_suppl.lba109

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available